Streetbeat News

Price Targets

EVRI

B. Riley Securities analyst David Bain has maintained a 'Buy' rating on Everi Hldgs (NYSE:EVRI) but lowered the price target from $27 to $24.

Portfolio Pulse from jenniferd'souza@benzinga.com

August 10, 2023 | 12:47 pm

APP

Credit Suisse analyst Stephen Ju has maintained an 'Outperform' rating on AppLovin (NASDAQ:APP) and raised the price target from $49 to $57.

Portfolio Pulse from richadhand@benzinga.com

August 10, 2023 | 12:47 pm

TRP

Credit Suisse analyst Andrew Kuske has maintained a Neutral rating on TC Energy and lowered the price target from C$55.5 to C$54.

Portfolio Pulse from richadhand@benzinga.com

August 10, 2023 | 12:46 pm

SLF

Credit Suisse analyst Kevin Choquette has maintained an 'Outperform' rating on Sun Life Financial (NYSE:SLF), but lowered the price target from $79 to $77.

Portfolio Pulse from richadhand@benzinga.com

August 10, 2023 | 12:44 pm

TBLA

Credit Suisse analyst Stephen Ju has maintained an Outperform rating on Taboola.com (NASDAQ:TBLA) and raised the price target from $5.5 to $5.7.

Portfolio Pulse from richadhand@benzinga.com

August 10, 2023 | 12:43 pm

GDRX

RBC Capital analyst Sean Dodge maintains a Sector Perform rating on GoodRx Holdings (NASDAQ:GDRX) and raises the price target from $6 to $8.

Portfolio Pulse from jenniferd'souza@benzinga.com

August 10, 2023 | 12:43 pm

BLDE

Credit Suisse analyst Stephen Ju has maintained an 'Outperform' rating on Blade Air Mobility (NASDAQ:BLDE), but lowered the price target from $8 to $7.

Portfolio Pulse from richadhand@benzinga.com

August 10, 2023 | 12:42 pm

ZLAB

Cantor Fitzgerald analyst Louise Chen has initiated coverage on Zai Lab (NASDAQ:ZLAB) with an Overweight rating and a price target of $70.

Portfolio Pulse from richadhand@benzinga.com

August 10, 2023 | 12:40 pm

CRMD

RBC Capital analyst Gregory Renza has initiated coverage on Cormedix (NASDAQ:CRMD) with an Outperform rating and a price target of $6.

Portfolio Pulse from richadhand@benzinga.com

August 10, 2023 | 12:39 pm

STN

Canaccord Genuity analyst Yuri Lynk has downgraded Stantec (TSX:STN) from Buy to Hold and raised the price target from C$91 to C$92.

Portfolio Pulse from richadhand@benzinga.com

August 10, 2023 | 12:37 pm